New York State Common Retirement Fund’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$180K Hold
11,746
﹤0.01% 2416
2026
Q1
$163K Hold
11,746
﹤0.01% 2314
2025
Q4
$162K Hold
11,746
﹤0.01% 2374
2025
Q3
$287K Hold
11,746
﹤0.01% 2141
2025
Q2
$271K Sell
11,746
-4,689
-29% -$124K ﹤0.01% 2129
2025
Q1
$444K Buy
16,435
+471
+3% +$17.8K ﹤0.01% 1924
2024
Q4
$855K Buy
15,964
+7,318
+85% +$387K ﹤0.01% 1746
2024
Q3
$393K Sell
8,646
-2,900
-25% -$126K ﹤0.01% 2026
2024
Q2
$484K Buy
11,546
+4,307
+59% +$202K ﹤0.01% 2054
2024
Q1
$273K Buy
7,239
+2,189
+43% +$47.7K ﹤0.01% 2309
2023
Q4
$54.2K Sell
5,050
-35
-0.7% -$303 ﹤0.01% 2969
2023
Q3
$51.3K Buy
5,085
+55
+1% +$634 ﹤0.01% 3017
2023
Q2
$59.7K Sell
5,030
-8,218
-62% -$110K ﹤0.01% 3093
2023
Q1
$160K Buy
13,248
+13
+0.1% +$216 ﹤0.01% 2683
2022
Q4
$174K Sell
13,235
-24
-0.2% -$351 ﹤0.01% 2786
2022
Q3
$180K Buy
13,259
+5,246
+65% +$70.1K ﹤0.01% 2808
2022
Q2
$98K Sell
8,013
-7,508
-48% -$88.9K ﹤0.01% 3065
2022
Q1
$223K Buy
15,521
+6,000
+63% +$98.2K ﹤0.01% 2783
2021
Q4
$188K Buy
9,521
+7,221
+314% +$151K ﹤0.01% 2895
2021
Q3
$50K Buy
+2,300
New +$66.2K ﹤0.01% 3240

Other funds holding JANX

New York State Common Retirement Fund's JANX Position: Q2 2026 in Review

New York State Common Retirement Fund held its Janux Therapeutics (JANX) position steady in Q2 2026 at 11,746 shares worth $180K. The position accounts for ﹤0.01% of the portfolio, ranked #2416.

New York State Common Retirement Fund first reported a position in JANX in Q3 2021 and has held it in 20 quarters since. The position peaked at $855K in Q4 2024. 67 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • New York State Common Retirement Fund held 11,746 shares of Janux Therapeutics worth $180K as of Q2 2026.
  • New York State Common Retirement Fund left its Janux Therapeutics share count unchanged in Q2 2026.
  • Janux Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2416 holding.
  • New York State Common Retirement Fund first reported a position in Janux Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • New York State Common Retirement Fund's Janux Therapeutics position peaked at $855K in Q4 2024.
  • 67 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.